类花生酸作为CKD超滤过介导损伤的生物标志物
该研究分析了CKiD生物样本库318例CKD患儿和72例遗尿对照的基线尿样,用质谱检测类花生酸代谢物。结果发现从CKD2期到3期,尿PGE2、血栓素和DHETs升高,而前列环素、F2-异前列腺素和DiHOMEs降低,提示COX和CYP450通路代谢紊乱;部分类花生酸与初始GFR相关,但与GFR变化或肾脏替代治疗时间无关。
要点
- 尿PGE2、血栓素和DHETs从CKD2期到3期升高,前列环素、F2-异前列腺素和DiHOMEs降低。
- 基线尿前列环素、PGE2/前列环素比值、血栓素/前列环素比值、LTE4、9,10-DiHOME和F2-异前列腺素与初始GFR显著相关。
- 无类花生酸与GFR随时间变化或肾脏替代治疗时间相关。
核心结论
- 首次报告CKD患儿亚油酸衍生代谢物变化,部分尿类花生酸与初始GFR相关,但需纵向研究验证其作为超滤过早期生物标志物。
研究设计与样本
- 基于CKiD生物样本库的横断面分析,纳入318例CKD患儿和72例遗尿对照,采用液相或气相色谱-质谱联用检测尿类花生酸代谢物(ng/mg肌酐)。
主要发现
- CKiD队列中CAKUT占71%(n=226),肾小球疾病占29%(n=92);CAKUT受试者中27%和73%分别处于CKD2期和3期,肾小球疾病中42%和58%分别处于CKD2期和3期。
- 从CKD2期到3期,尿PGE2、血栓素和DHETs升高,前列环素、F2-异前列腺素和9,10-DiHOMEs降低。
- 未调整混合模型中,基线类花生酸浓度加倍与初始GFR的关联显示:前列环素、PGE2/前列环素比值、血栓素/前列环素比值、LTE4、9,10-DiHOME和F2-异前列腺素与较高初始GFR显著相关,校正CAKUT诊断、性别、基线年龄、蛋白尿和高血压后仍显著。
- 无类花生酸与GFR随时间变化或肾脏替代治疗时间相关。
临床怎么用
- 目前证据尚不支持将尿类花生酸作为CKD进展的常规监测指标,但可为超滤过损伤的早期识别提供研究线索。
局限性
- 横断面设计无法确定因果关系,需纵向研究验证类花生酸作为超滤过早期生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Early biomarkers of hyperfiltration-induced injury are not known. We previously reported elevated urinary prostaglandin E2 (PGE2) preceding albuminuria in children with solitary kidney, and upregulated cyclooxygenase-2 (COX2)-PGE2-EP2 axis in unilaterally nephrectomized mice. To determine chronic kidney disease (CKD) stage-associated changes in urinary eicosanoids, baseline urine samples from the CKD in children (CKiD) biorepository (n = 318) and a comparator group of children with enuresis (n = 72) were analyzed. METHODS: Liquid or gas chromatography-mass spectrometry was used to measure metabolites of arachidonic acid and linoleic acid (ng/mg creatinine, P ≤ 0.05). RESULTS: The CKiD cohort included children with congenital anomalies of the kidney and urinary tract (CAKUT) (71%, n = 226) and glomerular disease (29%, n = 92). Glomerular filtration rate (GFR) measurement (Iohexol) showed 27% and 73% of CAKUT subjects at CKD stages 2 and 3, respectively. Among those with glomerular disease, 42% and 58% were at CKD stages 2 and 3, respectively. Comparisons across CKD stages identified increase in urinary PGE2, thromboxane, and dihydroxy eicosatrienoic acids (DHETs), with a decrease in prostacyclin, F2-isoprostane, and 9,10-dihydroxy-octadecenoic acids (DiHOMEs) from CKD stage 2 to 3 indicating perturbed metabolism through COX and cytochrome P-450 (CYP450) pathways. In unadjusted mixed models quantifying the associations of a 2-times higher baseline eicosanoid with initial GFR found prostacyclin, PGE2/prostacyclin ratio, thromboxane/prostacyclin ratio, LTE4, 9,10-DiHOME, and F2-Isoprostane were significantly associated with higher initial GFR and remained significant after adjusting for CAKUT diagnosis, sex and baseline age, proteinuria, and hypertension. However, none of the eicosanoids were associated with change in GFR over time or time to kidney replacement therapy. CONCLUSION: We report for the first time linoleic acid-derived metabolites in children with CKD. A longitudinal study is needed to validate selected urinary eicosanoids as early biomarkers of hyperfiltration.
引用
- Srivastava T, Milne GL, Zhou J, et al. Eicosanoids as Biomarkers of Hyperfiltration-Mediated Injury in CKD. Kidney Int Rep. 2026. PMID: 42891043. doi:10.1016/j.ekir.2026.107052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。